ORF cDNAクローンを検索してください

検索サポート

以下のような検索ワードを入力できます:

  • Entrez Gene ID (e.g. 7157)
  • gene symbol (e.g. TP53)
  • gene name (e.g. tumor protein p53)
  • gene synonyms (e.g. FLJ92943)
  • Ensembl ID (e.g. ENSG0000141510)
  • Accession No. (e.g. NM_000546)
  • 種名は、キーワードの後に ”キーワード[species:$species]” という形式で入力できます。ここで、$speciesは種の名称(ヒトやラットなど)、または分類群id (9606など)を入力します。

さらに検索するには こちらをクリック.


Rattus norvegicus (Norway rat) CD28 co-stimulation (provided by Reactome)

30 gene

The longest variant of each gene is displayed. Click the see gene variants link to see all gene variants.


Gene Symbol Full Name
Trib3 tribbles pseudokinase 3
Map3k14 mitogen-activated protein kinase kinase kinase 14
Grb2 growth factor receptor bound protein 2
Mapkap1 mitogen-activated protein kinase associated protein 1
Pak1 p21 (RAC1) activated kinase 1
Pak3 p21 (RAC1) activated kinase 3
Rictor RPTOR independent companion of MTOR, complex 2
Cd28 Cd28 molecule
Prr5 proline rich 5
Cd80 Cd80 molecule
Lck LCK proto-oncogene, Src family tyrosine kinase
Lyn LYN proto-oncogene, Src family tyrosine kinase
Cdc42 cell division cycle 42
Vav1 vav guanine nucleotide exchange factor 1
Rac1 ras-related C3 botulinum toxin substrate 1
Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
Pdpk1 3-phosphoinositide dependent protein kinase-1
Mtor mechanistic target of rapamycin kinase
Pak2 p21 protein (Cdc42/Rac)-activated kinase 2
Cd86 CD86 molecule
Src SRC proto-oncogene, non-receptor tyrosine kinase
LOC685590 similar to Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase p110 subunit alpha) (PtdIns-3-kinase p110) (PI3K)
Pik3r1 phosphoinositide-3-kinase regulatory subunit 1
Yes1 YES proto-oncogene 1, Src family tyrosine kinase
Them4 thioesterase superfamily member 4
Fyn FYN proto-oncogene, Src family tyrosine kinase
Map3k8 mitogen-activated protein kinase kinase kinase 8
Akt1 AKT serine/threonine kinase 1
LOC100910732 serine/threonine-protein kinase PAK 2-like
Mlst8 MTOR associated protein, LST8 homolog
overview_MB_2022